Macular Degeneration Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Macular Degeneration clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Visual Frailty in Ageing

Cognitive ImpairmentDepressionAnxiety+5 more
University of Edinburgh20 enrolled2 locationsNCT06604104
Recruiting
Phase 3

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Neovascular Age-related Macular Degeneration
Jaeb Center for Health Research600 enrolled64 locationsNCT05904028
Recruiting

"My Eyes, My Light": Amar Chokh, Amar Alo

MyopiaDiabetic Retinopathy (DR)Presbyopia+6 more
Data Yakka, Inc.20,000 enrolled1 locationNCT07135570
Recruiting
Not Applicable

Village-Integrated Eye Worker Trial II

Age-Related Macular DegenerationDiabetic RetinopathyGlaucoma
University of California, San Francisco60,200 enrolled1 locationNCT03752840
Recruiting
Not Applicable

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Age-Related Macular DegenerationDiabetic RetinopathyCataract+2 more
University of Copenhagen460 enrolled2 locationsNCT07015034
Recruiting
Not Applicable

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Primary Open Angle GlaucomaMacular Degeneration, Dry
Medical University of Vienna35 enrolled1 locationNCT03921931
Recruiting

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD

AnxietyDepression DisordersAMD - Age-Related Macular Degeneration
Fondazione G.B. Bietti, IRCCS22 enrolled1 locationNCT06906003
Recruiting
Not Applicable

Stem Cell Ophthalmology Treatment Study II

Age-Related Macular DegenerationRetinitis PigmentosaMacular Degeneration+15 more
MD Stem Cells500 enrolled4 locationsNCT03011541
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

CancerLymphomaLeukemia+44 more
Sanguine Biosciences20,000 enrolled1 locationNCT05635266